Erasca, Inc. (ERAS)

15.50 -0.11 (-0.70%) USD  |  NASDAQ  |  Nov 10, 16:00
15.50 0.00 (0.00%) After-Hours: 20:00
More

Erasca Cash from Operations (Annual) : -95.46M for Dec. 31, 2025

Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -95.46M
December 31, 2024 -109.42M
December 31, 2023 -101.22M
December 31, 2022 -103.26M
Date Value
December 31, 2021 -79.60M
December 31, 2020 -32.69M
December 31, 2019 -10.38M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 179.55M
Twist Bioscience Corp. -47.63M
Immunome, Inc. -190.92M
Oncolytics Biotech, Inc. -20.11M
Sangamo Therapeutics, Inc. -97.21M